Trademark: 88600290
Word
AVANIA
Status
Registered
Status Code
700
Status Date
Tuesday, June 2, 2020
Serial Number
88600290
Registration Number
6071106
Registration Date
Tuesday, June 2, 2020
Mark Type
4000
Filing Date
Friday, August 30, 2019
Published for Opposition
Tuesday, January 21, 2020

Trademark Owner History

Classifications
41 Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports
35 Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management; Medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; Business consulting services in the field of medical coding in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; Providing reimbursement services, namely, providing business advice and information relating to reimbursement strategies and support to companies involved in the healthcare field
45 Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields
42 Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, including orthopedic, cardiovascular, dermatology, and aesthetics; consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the Food and Drug Administration (FDA) by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices

Trademark Events
Apr 24, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 24, 2023
Teas Change Of Correspondence Received
Apr 24, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 24, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 24, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 24, 2023
Teas Change Of Owner Address Received
Jan 20, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 20, 2023
Teas Change Of Correspondence Received
Jan 20, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 20, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 20, 2023
Teas Change Of Owner Address Received
Mar 9, 2022
Automatic Update Of Assignment Of Ownership
Jun 2, 2020
Registered-Principal Register
Apr 30, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Apr 29, 2020
Allowed Principal Register - Sou Accepted
Apr 3, 2020
Statement Of Use Processing Complete
Mar 17, 2020
Use Amendment Filed
Apr 3, 2020
Case Assigned To Intent To Use Paralegal
Mar 17, 2020
Teas Statement Of Use Received
Mar 17, 2020
Noa E-Mailed - Sou Required From Applicant
Jan 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 21, 2020
Published For Opposition
Jan 1, 2020
Notification Of Notice Of Publication E-Mailed
Dec 13, 2019
Assigned To Lie
Dec 10, 2019
Approved For Pub - Principal Register
Dec 10, 2019
Examiner's Amendment Entered
Dec 10, 2019
Notification Of Examiners Amendment E-Mailed
Dec 10, 2019
Examiners Amendment E-Mailed
Dec 10, 2019
Examiners Amendment -Written
Dec 4, 2019
Assigned To Examiner
Sep 12, 2019
New Application Office Supplied Data Entered
Sep 3, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24